Among the highest-paid bosses in the UK is pharmaceutical group AstraZeneca’s chief Pascal Soriot, who took home a pay packet ...

Pay for executives at Britain's biggest-listed companies has hit a new record high, as more FTSE 100 firms paid top bosses at ...

Median pay for chief executive officers of FTSE 100 companies was £4.58 million in the 2024-2025 financial year.

There were 13 companies on the index of the UK’s top 100 listed firms paying their chief executives £10 million or more (PA) ...

The US drugmaker Eli Lilly has bowed to demands from Donald Trump by raising the prices of its weight-loss jab for UK ...

So Sir Pascal may seem an unlikely ally of Donald Trump, who as America’s president has slashed public spending on scientific ...

We will be totally self-sufficient for the supply of medicines to American patients.” AstraZeneca CEO Pascal Soriot on the ...

Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a ...

He said about Britain that the firm needed “to see that there is access and a reason to invest.” This is partly a negotiating tactic to get a better deal from the British government, including on what ...

British-Swedish company AstraZeneca was first up to the plate on Tuesday. In a second-quarter earnings call with journalists, CEO Pascal Soriot was sanguine about the impact of the tariffs.

Pharmaceutical CEOs are on notice about sky-high drug prices as President Donald Trump demands a recalibration of what Americans are paying compared to other countries.

AstraZeneca has proposed U.S. drug price cuts following a $50 billion investment plan as it faces pressure from the Trump administration. CEO Pascal Soriot noted that the company's proposal is under ...